An overview of who we are, and what we do.

1. Boehringer Ingelheim
delivering more health to patients and families for more than 125 years

2. Who We Are
For more than125 years
Boehringer Ingelheim
has been committed to
the research and
development of
innovative medicines
that improve the lives of
patients and their
families
2

3. Who We Are
We think long Our products We’re committed
term and invest help patients and to doing the
heavily in science their families right thing
3

4. More than 125 Years of Innovating for Patients and Families
Founded 1885
in Ingelheim, Germany
Family-owned Privately-held
global company for more than 125 years
Products marketed in $17.1 billion 44,000
150+ countries 2011 net sales employees worldwide
Focus on
23.5 % of sales Human
invested back Pharmaceuticals
into R&D & Animal Health
4

5. 125 Years of Innovating for Patients and Their Families
1885 2010
Albert Boehringer
buys a small
tartaric acid 1941
Revolutionary
2002 First new
factory in
aludrin® for product in
Ingelheim,
asthma treatment category in
Germany
introduced 50+ years
34,221 employees
22,254 employees
28 employees 44,000 employees
1985 2003 2011
1912
First pharmaceutical 100th Anniversary
Inhaler device
product laudanon®
registered First approved
for pain launched
Biopharma product
production from BI’s
investment alliance with Eli
Lilly and
5 Company

6. Our World Net Sales
29 June 2012
PLEASE INSERT Presentation title 6

7. Research and Development Centers Around the World
Laval (Canada)
Infectious Disease Biberach &
Ingelheim (Germany)
Cardiometabolic Diseases
Respiratory Diseases
Neurological Diseases
Ridgefield (USA)
Immunology & Inflammation
Cardiometabolic Diseases Vienna (Austria)
Oncology
7

8. Focused on Innovation
Metabolic
Diseases
Immunology &
Inflammation Oncology
Respiratory Infectious
Diseases Diseases
Central Nervous
Cardiovascular
System (CNS)
Diseases
Disorders
8

9. Focused on Innovation:
Marketed Prescription Medications
9

10. Focused on Research Innovation:
Investigating New Treatments for Patients
Therapeutic Areas Phase III Phase II
Afatinib
Oncology Volasertib
Nintedanib
Type 2 Diabetes Empagliflozin
Olodaterol
Respiratory Tiotropium (Asthma)
Nintedanib
Hepatitis C BI201335 BI 207127
10

11. A Great Place to Work
Human Rights Campaign
Best Places to Work
2011 Top 50 Company for
Female Executives
Best Employers
for
Healthy Lifestyles
Top Employers
Trainer’s
Choice Award
11

12. We Care for Our Employees
Fitness center and Health/wellness
programs programs
Workplace On-site
flexibility childcare
12

13. We Care for Our Communities
We are a family company with a 125-year heritage of providing more health for our communities.
Our caring culture embraces a broad range of activities that include:
Corporate Social Responsibility
• Boehringer Ingelheim AmeriCares Free Clinic
• Science Horizons Regional Science Fair
• United Way Day of Caring
Volunteerism
• Our employees are passionate about helping
improve the lives of people in our community
• In 2011 U.S. employees volunteered more than
15,000 hours of their time
13

14. BI Cares Foundation
In keeping with our commitment to do the most good for the most people,
we work hard to ensure our medicines are accessible to eligible patients
who need them, including senior citizens and families on limited incomes.
Through the
BI Cares Foundation
our Patient Assistance Programs help
those in need obtain medications
free of charge.
In 2011,
more than 63,000
eligible patients received assistance
through these programs.
14

15. Where We Are in the United States
BI Vetmedica, Inc. Ben Venue Laboratories, Inc.
St. Joseph, MO Bedford Laboratories™
(Animal Health) Bedford, OH
(Sterile Injectables)
Established in U.S. in 1971
More than 10,000 U.S. Employees
Headquartered in Ridgefield, CT
BI Pharmaceuticals, Inc.
Seven U.S. Subsidiaries Ridgefield, CT
(Prescription Medicines, Consumer Health
Care, Research & Development)
BI Fremont, Inc.
Fremont, CA
(Biopharmaceuticals)
BI Roxane, Inc. BI Chemicals, Inc.
Roxane Laboratories Petersburg, VA
Columbus, OH (Active Pharmaceutical Ingredient
(Generics and Distribution) Manufacturing)
15

16. Where We Are in the United States
Worldwide Center of
Excellence in immunology,
inflammatory disease, and
cardiovascular research
Boehringer Ingelheim
Consumer Health Care Pharmaceuticals, Inc. (BIPI)
Marketers of Zantac® and
Dulcolax® products Ridgefield, CT headquarters
Prescription medicines Southbury, CT training facility
Clinical Research
Development Field-based salesforce
Marketing
3,500 employees
16

17. Where We Are in the United States
A leading producer of
advanced, high-quality active
Boehringer Ingelheim Chemicals, Inc.
human pharmaceutical
ingredients (APIs) for BI and Petersburg, VA
third-party customers
350 employees
17

18. Where We Are in the United States
Ben Venue Laboratories, Inc.
Contract Marketing
• A leading manufacturer of liquid and
freeze-dried sterile injectable drugs for
the global pharmaceutical industry
• BVL offers one of the largest contract
lyophilization capacities worldwide Ben Venue Laboratories, Inc.
Bedford Laboratories Bedford Laboratories
• Markets specialty multisource injectable Bedford, OH
products to hospitals in North America
• Offers 92 products in 279 More than 1,400 Employees
presentations, including seven sole
source generics
• Most comprehensive line of generic
injectable oncology products in North
America
18

19. Where We Are in the United States
Brand Production Site
• Spiriva® • Combivent®
• Mirapex® • Micardis®
Boehringer Ingelheim Roxane, Inc.
• Viramune® • Aptivus®
Columbus, OH
Multisource Launch Site
900 Employees
• Prescription Medicines, Generics
and Consumer Health Care
• Two Distribution Centers
(Columbus and Reno)
19

20. Where We Are in the United States
Solid/Liquid/Inhalation Generics
16 – 20 abbreviated new drug
applications filed per year
8 – 12 product launches per year
Market Strategy: Roxane Laboratories
Differentiation
Columbus, OH
• Paragraph IV filings
120 Employees
• Complex formulations/clinical
trials
• Internal Intellecutal Property
• Potent Compounds
• DEA Quota Controlled
Substances
20

21. Where We Are in the United States
Boehringer Ingelheim Vetmedica, Inc.
St. Joseph, MO
• Biological research, development and manufacturing Elwood, KS
• Dedicated to improving lives and well-being of animals Sioux Center, IA
• High-quality products for cattle, swine, horses and pets Ames, IA
• Acquired significant portion of Fort Dodge Animal Health Fort Dodge, IA
business in 2009
1,900 employees
21

22. Where We Are in the United States
Boehringer Ingelheim Fremont, Inc.
Fremont, CA
• Key manufacturing site for BI Biopharmaceutical
Contract Manufacturing in the U.S. 300 Employees
• State-of-the-art facility with 200,000 + sq. ft for
laboratories, manufacturing and process development
• Key product is Amgen’s Vectibix®
22